Secondary cancers in childhood;Second cancer en pédiatrie?

Revue Medicale de Liege

Volumn 61, Issue 2, 2006, Pages 76-80

  Forget, P ^a   Dresse, M F ^a   Schmitz, V ^a   Hoyoux, Cl ^a  

^a Service Universitaire d'Hemato Oncologie Pediatrique   (Belgium)

Author keywords

Hereditary predisposition; Radio and chemotoxicity; Secondary malignant neoplasm (SMN)

Indexed keywords

ALKYLATING AGENT; ANTHRACYCLINE ANTIBIOTIC AGENT; ANTIMETABOLITE; ANTINEOPLASTIC AGENT; BUSULFAN; CISPLATIN; CYCLOPHOSPHAMIDE; DOXORUBICIN; EPIPODOPHYLLOTOXIN; ETOPOSIDE; GYRASE INHIBITOR; MELPHALAN; MERCAPTOPURINE; METHOTREXATE; TIOGUANINE;

ACUTE MYELOBLASTIC LEUKEMIA; ARTICLE; ATAXIA TELANGIECTASIA; BLOOM SYNDROME; BONE MARROW TRANSPLANTATION; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SUSCEPTIBILITY; CELL PROLIFERATION; CHILDHOOD CANCER; FAMILIAL CANCER; GENETIC PREDISPOSITION; HODGKIN DISEASE; HUMAN; NEUROFIBROMATOSIS; RETINOBLASTOMA; RISK FACTOR; RISK REDUCTION; SECOND CANCER; SOLID TUMOR; XERODERMA PIGMENTOSUM; ADJUVANT CHEMOTHERAPY; ADJUVANT THERAPY; CHILD; GENETICS; PATHOLOGY; REVIEW;

CHEMOTHERAPY, ADJUVANT; CHILD; GENETIC PREDISPOSITION TO DISEASE; HUMANS; NEOPLASMS, SECOND PRIMARY; RADIOTHERAPY, ADJUVANT; RISK FACTORS;

EID: 33644745182     PISSN: 00353663     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Kodym R.- Secondary malignancies after multimodality treatment regimens. Front Radiat Ther Oncol, 2002, 37, 84-91.
2. Meadows AT, Fenton JG.- Follow up care of patients at risk for the development of second malignant neoplasms. Survivors of childhood cancer assessment and management, 1994, 16, 319-327.
3. Meadows AT, Baum E, Fossati-Bellani F, et al.- Second malignant neoplasms in children: an update from the Late Effects Study Group. J Clin Oncol, 1985, 3, 532-538.
4. Gow KW, Lensing S, Hill DA, et al.- Thyroid carcinoma presenting in childhood or after treatment of childhood malignancies: an institutional experience and review of the literature. J Pediatr Surg, 2003, 38, 1574-1580.
5. Wolden SL, Lamborn KR, Cleary SF, et al.- Second cancers following pediatric Hodgkin disease. J Clin Oncol, 1998, 16, 536-544.
6. Hildreth NG, Shore RE, Dvoretsky PM.- The risk of breast cancer after the irradiation of the thymus in infancy. N Engl J Med, 1989, 321, 1281-1284.
7. Boice JD, Blettner M, Kleinerman RA, et al.- Radiation dose and leukemia risk in patients treated for cancer of the cervix. J Natl Cancer Inst, 1987, 79, 1295-1311.
8. Boice JD, Engholm G, Kleinerman RA, et al.- Radiation dose and second cancer risk in patients in patients treated for cancer of the cervix. Radiat Res, 1988, 116, 3-55.
9. Tucker MA.- Therapeutic radiation at a young age is linked to secondary thyroid cancer. Cancer Res, 1991, 51, 2885-2888.
10. Fraser MC, Tucker MA.- Second malignancies following cancer therapy. Semin Oncol Nurs, 1989, 5, 43-55.
11. Bathia S, Robison LL, Oberlin O, et al.- Breast cancer and other second neoplasms after childhood Hodgkin's disease. N Engl J Med, 1996, 334, 745-751.
12. Felix CA.- Secondary leukemias induced by topoisomerase-targeted drugs. Biochim Biophys Acta, 1998, 1400, 233-255.
13. Curtis RE, Boice JD, Stovall M, et al.- Risk of leukemia after chemotherapy and radiation treatment for breast cancer. N Engl J Med, 1992, 326, 1745-1751.
14. Karp JE, Smith MA.- The molecular pathogenesis of treatment induced secondary leukemias: Foundations for treatment and prevention. Semin Oncol, 1997, 24, 103-113.
15. Deeg HJ, Whiterspoon RR- Risk factors for the development of secondary malignancies after marrow transplantation. Hematol Oncol Clin N Am, 1993, 7, 417-429.
16. Whiterspoon RP, Fisher I, Schoch G, et al.- Secondary cancers after bone marrow transplantation for leukemia or aplastic anemia. N Engl J Med, 1989, 321, 784-789.
17. Bathia S, Ramsay N, Steinbach M, et al.- Malignant neoplasms following bone marrow transplantation. Blood, 1996, 87, 3633-3639.
18. Traweek ST, Slovak ML, Nademanee AP, et al.- Clonal karyotypic hematopoietic cell abnormalities occurring after autologous bone marrow transplantation for Hodgkin's disease and non- Hodgkin's lymphoma. Blood, 1994, 84, 957-963.
19. Darrington DL, Vose JM, Anderson JR, et al.- Incidence and characterization of secondary myelodysplastic syndrome and acute myelogenous leukemia following high-dos chemoradiotherapy and autologous stem-cell transplantation for lymphoid malignancies. J Clin Oncol, 1994, 12, 2527-2534.
20. Neglia JP, et al.- Second neoplasms after acute lymphoblastic leukemia in childhood. N Engl J Med, 1991, 325, 1330-1336.
21. Chen H, Sandler DP, Taylor JA, et al.- Increased risk for myelodysplastic syndromes in individuals with gluthathione transferase theta 1 (GSTT1) gene defect. Lancet, 1996, 347, 295-297.